DK1618873T3 - Granulat til kontrolleret frigivelse af tamsulosin, indeholdende alginat - Google Patents

Granulat til kontrolleret frigivelse af tamsulosin, indeholdende alginat

Info

Publication number
DK1618873T3
DK1618873T3 DK04016523T DK04016523T DK1618873T3 DK 1618873 T3 DK1618873 T3 DK 1618873T3 DK 04016523 T DK04016523 T DK 04016523T DK 04016523 T DK04016523 T DK 04016523T DK 1618873 T3 DK1618873 T3 DK 1618873T3
Authority
DK
Denmark
Prior art keywords
tamsulosin
granules
controlled release
polyvinyl acetate
acetate phthalate
Prior art date
Application number
DK04016523T
Other languages
Danish (da)
English (en)
Inventor
Eszter Julianna Dr Biro
Waltraud Dr Bueb
Original Assignee
Siegfried Generics Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Generics Int Ag filed Critical Siegfried Generics Int Ag
Application granted granted Critical
Publication of DK1618873T3 publication Critical patent/DK1618873T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK04016523T 2004-07-14 2004-07-14 Granulat til kontrolleret frigivelse af tamsulosin, indeholdende alginat DK1618873T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04016523A EP1618873B1 (de) 2004-07-14 2004-07-14 Granulat zur kontrollierten Freisetzung von Tamsulosin, enthaltend Alginat

Publications (1)

Publication Number Publication Date
DK1618873T3 true DK1618873T3 (da) 2007-10-08

Family

ID=34925746

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04016523T DK1618873T3 (da) 2004-07-14 2004-07-14 Granulat til kontrolleret frigivelse af tamsulosin, indeholdende alginat

Country Status (15)

Country Link
US (1) US20090130200A1 (sl)
EP (1) EP1618873B1 (sl)
AT (1) ATE363894T1 (sl)
AU (1) AU2005261958A1 (sl)
CA (1) CA2570153A1 (sl)
DE (1) DE502004004032D1 (sl)
DK (1) DK1618873T3 (sl)
ES (1) ES2287613T3 (sl)
NO (1) NO20070559L (sl)
PL (1) PL1618873T3 (sl)
PT (1) PT1618873E (sl)
SI (1) SI1618873T1 (sl)
TW (1) TW200613007A (sl)
WO (1) WO2006005512A1 (sl)
ZA (1) ZA200700216B (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20052461A1 (it) * 2005-12-22 2007-06-23 Univ Degli Studi Milano Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive
US20080113030A1 (en) * 2006-11-09 2008-05-15 Ching-Fen Hsiao Sustained release tamsulosin formulations
DE102007009242A1 (de) * 2007-02-22 2008-09-18 Evonik Röhm Gmbh Pellets mit magensaftresistenter Wirkstoff-Matix
EP2949319A1 (en) 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
WO2017160106A2 (ko) * 2016-03-16 2017-09-21 한미약품 주식회사 두타스테라이드 및 탐수로신 함유 경질 캡슐 복합제 및 그 제조방법
MX2018013473A (es) * 2016-05-04 2019-02-28 Aspen Park Pharmaceuticals Inc Clorhidrato de tamsulosina oral de liberacion retardada.
EP3473245A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
EP3473244A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
CN115300506A (zh) * 2022-08-11 2022-11-08 南京红地生物科技有限公司 含有坦索罗辛和米拉贝隆的复方制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US6251430B1 (en) * 1998-02-04 2001-06-26 Guohua Zhang Water insoluble polymer based sustained release formulation
US7255876B2 (en) * 2001-07-27 2007-08-14 Astellas Pharma, Inc. Composition comprises sustained-release fine particles and manufacturing method thereof
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
KR100510270B1 (ko) * 2002-11-29 2005-08-26 센츄론(주) 펠렛타이저를 이용한 서방성 제제의 제조방법
IN192381B (sl) * 2002-12-20 2004-04-10 Ranbaxy Lab

Also Published As

Publication number Publication date
CA2570153A1 (en) 2006-01-19
TW200613007A (en) 2006-05-01
SI1618873T1 (sl) 2007-10-31
DE502004004032D1 (de) 2007-07-19
US20090130200A1 (en) 2009-05-21
ATE363894T1 (de) 2007-06-15
PT1618873E (pt) 2007-09-04
ZA200700216B (en) 2008-05-28
EP1618873B1 (de) 2007-06-06
PL1618873T3 (pl) 2008-01-31
AU2005261958A1 (en) 2006-01-19
NO20070559L (no) 2007-01-30
WO2006005512A1 (en) 2006-01-19
ES2287613T3 (es) 2007-12-16
EP1618873A1 (de) 2006-01-25

Similar Documents

Publication Publication Date Title
NO20070559L (no) Granuler for kontrollert frigjoring av tamsulosin
RU2008130891A (ru) Твердый препарат с контролируемым высвобождением
CO5690538A2 (es) Formulaciones de multiples particulas de pantoprazol
RU2014101228A (ru) Покрывающая композиция, подходящая для фармацевтических или нутрицевтических лекарственных форм
AR069500A1 (es) Metodos de tratamiento de la esteatohepatitis no alcoholica (nash ) utilizando productos de cisteamina
RU2014101227A (ru) Композиция покрытия, подходящая для фармацевтических или нутрицевтических лекарственных форм
WO2004112756A8 (en) Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
BR0107874A (pt) Implante farmacêutico para controlavelmente liberar uma droga, método para controlavelmente liberar uma droga em um indivìduo, e, método para preparar o implante
MX2013007588A (es) Comprimido de desintegracion oral.
HRP20060136A2 (en) Pellets containing venflaxine hydrochloride
RU2006101082A (ru) Фармацевтическая композиция с набухающим покрытием
MX2009008952A (es) Microesferas que comprenden una matriz de sustancia activa resistente a jugo gastrico.
HK1115308A1 (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
RU2001109431A (ru) Препараты ранолазина с пролонгированным действием
ATE310542T1 (de) Beschichtete implantate
TW200602085A (en) Controlled-release pharmaceutical composition and method for producing same
RU2008130892A (ru) Твердое лекарственное средство с контролируемым высвобождением
CA2581002A1 (en) Less abusable pharmaceutical preparations
TW200833372A (en) Use of (meth)acrylate copolymers in delayed-release pharmaceutical forms for decreasing the influence of ethanol on the release of active compound
RU2005121999A (ru) Фармацевтические композиции тамсулозина с контролируемым высвобождением
CA2797812A1 (en) Enteric tablet
EA200001201A2 (ru) Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем
AR071970A1 (es) Composicion de liberacion pulsatil de sildenafil y proceso para prepararla
PE84399A1 (es) Formas de dosificacion de sertralina de liberacion retardada
RU2012131952A (ru) Фармацевтическая композиция с модифицированным высвобождением, содержащая реин или диацереин и способ ее получения